0001853898-26-000001.txt : 20260402
0001853898-26-000001.hdr.sgml : 20260402
20260402100809
ACCESSION NUMBER: 0001853898-26-000001
CONFORMED SUBMISSION TYPE: D/A
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering
ITEM INFORMATION: Investment Company Act Section 3(c)
ITEM INFORMATION: Section 3(c)(7)
FILED AS OF DATE: 20260402
DATE AS OF CHANGE: 20260402
EFFECTIVENESS DATE: 20260402
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Paradigm BioCapital Partners Fund LP
CENTRAL INDEX KEY: 0001853898
ORGANIZATION NAME:
EIN: 851462439
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D/A
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-394372
FILM NUMBER: 26831128
BUSINESS ADDRESS:
STREET 1: C/O PARADIGM BIOCAPITAL GP LLC
STREET 2: 767 THIRD AVENUE, 17TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10017
BUSINESS PHONE: (646) 970-2568
MAIL ADDRESS:
STREET 1: C/O PARADIGM BIOCAPITAL GP LLC
STREET 2: 767 THIRD AVENUE, 17TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10017
D/A
1
primary_doc.xml
X0708
D/A
LIVE
0001853898
Paradigm BioCapital Partners Fund LP
C/O PARADIGM BIOCAPITAL GP LLC
767 THIRD AVENUE, 17TH FLOOR
NEW YORK
NY
NEW YORK
10017
(646) 970-2568
DELAWARE
None
None
Limited Partnership
true
N/A
Paradigm BioCapital GP LLC
767 Third Avenue
17th Floor
New York
NY
NEW YORK
10017
Promoter
The Issuer's General Partner
Senai
Asefaw
c/o Paradigm BioCapital GP LLC
767 Third Avenue, 17th Floor
New York
NY
NEW YORK
10017
Executive Officer
Managing Member of the Issuer's General Partner
Pooled Investment Fund
Hedge Fund
false
Decline to Disclose
- 06b
- 3C
- 3C.7
true
0001853898-25-000002
2021-04-01
true
true
false
5000000
Indefinite
105449654
Indefinite
false
42
0
true
0
true
0
true
Paradigm BioCapital GP LLC and/or its affiliates will receive customary management fees and/or performance allocations, as described in the Issuer's Confidential Private Placement Memorandum.
false
Paradigm BioCapital Partners Fund LP
/s/ Senai Asefaw
Senai Asefaw
Managing Member of the Issuer's General Partner
2026-04-02